Sirolimus as a second-line treatment for Graves' orbitopathy. Lanzolla G, Maglionico MN, Comi S, Menconi F, et al. J Endocrinol Invest 2022;45:2171-2180.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lanzolla G, Maglionico MN, Comi S, Menconi F, et al. Sirolimus as a second-line treatment for Graves' orbitopathy. J Endocrinol Invest 2022;45:2171-2180.
PMID: 35831587